Quest Diagnostics Declares Quarterly Cash Dividend
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX), a leading diagnostic information services provider, has announced a quarterly cash dividend of $0.80 per share. The dividend will be paid on July 21, 2025, to shareholders who are on record as of July 7, 2025. This regular dividend declaration demonstrates Quest's commitment to providing consistent returns to its shareholders.
Positive
- Regular dividend payment demonstrates financial stability and commitment to shareholder returns
- Maintains consistent dividend distribution policy
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, DGX gained 2.28%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302455896.html
SOURCE Quest Diagnostics